
Cureone TZ 250mg/31.25mg Injection
Marketer
Balsons Pharmaceutical
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cureone TZ 250mg/31.25mg Injection
Combiflox TZ, a 250mg/31.25mg injectable combination drug, combats various bacterial infections by hindering microbial proliferation. Administration must be under medical supervision; strict adherence to the prescribed dosage schedule is crucial for optimal efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician about all current medications, particularly if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and hydration promote recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Cureone TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cureone TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cureone TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cureone TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
How Cureone TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Cureone TZ 250mg/31.25mg) unites two active components to combat bacterial infections. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cureone TZ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cureone TZ 250mg/31.25mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to fetuses; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cureone TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cureone TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cureone TZ 250mg/31.25mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
For individuals with severe hepatic impairment, administering Cureone TZ 250mg/31.25mg Injection requires careful consideration and potential dosage modification. Medical advice is essential. Dosage alteration of Cureone TZ 250mg/31.25mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cureone TZ 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Cureone TZ 250mg/31.25mg Injection, seek medical advice from your physician.
Facts to Know About Cureone TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
